Melanoma is the deadliest and most aggressive type of skin cancer. Melanoma develops when melanocytes, the pigment-producing cells present in the skin, eye, inner ear, and leptomeninges, acquire genetic mutations. UV radiation is the primary cause of melanoma in people who have low amounts of the skin pigment melanin. Any skin lesion that has indications of being potentially malignant is biopsied and analyzed for diagnosis. Melanoma, a malignant cancer emerging from melanocytes, is a rare disease in the United States, affecting only 22.1 persons per 100,000. It is, nevertheless, a notably deadly disease, accounting for 75% of skin cancer deaths despite only accounting for 4% of skin cancer cases. The mnemonic "ABCDEF" summarizes the early signs of melanoma: Asymmetry, Borders (irregular with edges and corners), Color (variegated), Diameter (greater than 6 mm (0.24 in), Evolving over time
- Metastatic Melanoma
- Malignant Melanoma
- Combat Melanoma
- Scleroderma
- Biomarkers
Sergei A Grando
University of California Irvine, United States
Nalini Kaul
Princeton Consumer Research, Canada
Dechelette Corinne
La Peau Autrement, France
Salma Bennis
Nova Southeastern University, United States
Diane Madfes
Madfes Aesthetic Medical Center, United States
Abdullah Abdullah
Newham University Hospital, United Kingdom
Chajra Hanane
Activen, Switzerland
Dunia Battolla
Hapiderm Clinic, Switzerland
Camille Ysabel V Bautista
Jose R. Reyes Memorial Medical Center, PhilippinesSubmit your abstract Today
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Paraneoplastic Autoimmune Multiorgan Syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Art, skin, and dermatology: Interdisciplinary perspectives
Dechelette Corinne, La Peau Autrement, France
Title : Personalized and Precision Medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Lymphoproliferative diseases in the practice of a dermatologist
Sergeeva Irina, Novosibirsk State University, Russian Federation
Title : Assessing efficacy and safety of hair growth products in a clinical design using qualitative and quantitative techniques
Nalini Kaul, Princeton Consumer Research, Canada
Title : Integrating personalized and precision medicine into dermatology clinical practice securing its potential to get skin diseases cured and to revolutionize dermatooncology
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, The Clinic of Plastic Surgery and Aesthetic Dermatology, Totalcharm, Georgia
Title : How a combined use of stem cells and laser technologies for face and neck rejuvenation can reduce patients’request for surgical correction
Elena Giardini, Private Practice, Italy
Title : Demographic and clinical profile of allergic contact dermatitis patients who tested positive with metal allergy from a tertiary hospital: A 12 year retrospective study
Camille Ysabel V Bautista, Jose R. Reyes Memorial Medical Center, Philippines